Premium
Utility of FDG‐PET/CT in the follow‐up of neuroblastoma which became MIBG‐negative
Author(s) -
Colavolpe Cécile,
Guedj Eric,
Cammilleri Serge,
Taïeb David,
Mundler Olivier,
Coze Carole
Publication year - 2008
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.21594
Subject(s) - medicine , neuroblastoma , blood cancer , stage (stratigraphy) , oncology , disease , minimal residual disease , radiology , nuclear medicine , cancer , leukemia , paleontology , genetics , biology , cell culture
We report on the case of a 10‐month‐old female infant with a metastatic neuroblastoma which became MIBG‐negative at time of relapse. We discuss the different hypothesis associated with this particular outcome, and the potential utility of FDG‐PET as an alternative to follow up the residual disease at this stage. Pediatr Blood Cancer 2008;51:828–831. © 2008 Wiley‐Liss, Inc.